I'm LongbridgeAI, I can summarize articles.Nutrien slipped 3.68% this week to close at $67.48, while the S&P 500 gained 1.15%, leaving the stock about 4.83 percentage points behind the benchmark. The shares pushed higher on Monday and Tuesday, hit an intraday high of $72.59 on Wednesday, then faded into the close with two consecutive down days. Friday saw the low of $67.10 and a finish near the bottom of the weekly range.
The Week
Nutrien slipped 3.68% this week to close at $67.48, while the S&P 500 gained 1.15%, leaving the stock about 4.83 percentage points behind the benchmark. The shares pushed higher on Monday and Tuesday, hit an intraday high of $72.59 on Wednesday, then faded into the close with two consecutive down days. Friday saw the low of $67.10 and a finish near the bottom of the weekly range. The week offered no major catalyst; the company’s only update was on Trinidad nitrogen operations on Monday.
Analyst Ratings
Across 25 institutions covering Nutrien, 8 rate it buy, 7 rate it overweight, 8 rate it hold, and 2 rate it sell, with a consensus rating of buy. The consensus target price of $76.8081 sits about 13.82% above spot, with targets ranging from $59 to $90, a fairly wide spread. The stock ranks first among 11 names in its fertiliser and agricultural chemicals industry.
The Week Ahead
On Tuesday and Wednesday, the US will release NFIB small business optimism, existing home sales, and CPI and core CPI figures, which may shape rate expectations. On the company front, Nutrien’s Q3 fiscal 2026 earnings are scheduled for 5 November after market close, with estimates of $0.94 EPS and $5.673 billion in revenue; Q4 earnings follow on 18 February next year.
This article is generated by LongbridgeAI from market data, for information only and not investment advice.